Home Tags MannKind Corp

Tag: MannKind Corp

MannKind expecting to ‘practically double in size’ with new hires in...

The drugmaker is looking to hire over 100 people in anticipation of FDA approval of Tyvaso DPI, used to treat pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease.

MannKind Corp. to produce new anti-hypertension supplies in Danbury

MannKind will receive an upfront payment of $45 million under a collaboration agreement with United Therapeutics Corp.

Mannkind announces new product development

Hakan Edstrom, the president, CEO and director of MannKind Corp., a biotech company based in Danbury, this morning announced that the development of pulmonary...